Adding docetaxel-based chemotherapy to standard treatment for high-risk prostate cancer
According to the American Cancer Society, prostate cancer is the second most common cause of cancer-related death among men in […]
» Read morenohealthproblemsnews.com
According to the American Cancer Society, prostate cancer is the second most common cause of cancer-related death among men in […] Researchers will answer that question today at the Society of Behavioral Medicine’s 40th Annual Meeting & Scientific Sessions. People living […] MONDAY, March 4, 2019 — Even when women have health insurance, high deductibles may delay them from having breast cancer […] So easy colon cancer can be Prevention An American research team recommends a new method for the early detection of […] In the fight against cancer, there is a surprising tool in the arsenal: the food we eat. That’s because some […] Evan White was a typical 24-year-old. A lifelong athlete and recent college graduate, when he started feeling exhausted after minimal […] TUESDAY, Feb. 26, 2019 — The community of bacteria or “microbiome” in a woman’s cervix might be a harbinger of […] Biologic age, a DNA-based estimate of a person’s age, is associated with future development of breast cancer, according to scientists […] A new “smart drug” has shown promise for women with metastatic triple-negative breast cancer, based on data from a clinical […] Healthy white blood cells, called “T-cells,” play a crucial role in how the body fights follicular lymphoma. That’s according to […]
Adding docetaxel-based chemotherapy to standard treatment for high-risk prostate cancer
Do rural populations experience greater worry and fatalism about cancer?
High Deductibles May Threaten Breast Cancer Patients’ Survival
Study: New cancer screening with colorectal cancer screening test for the home
Study finds that in mice, lycopene in tomatoes reduced fatty liver disease, inflammation and liver cancer
Colorectal cancer on the rise among young people
Cervical ‘Microbiome’ Could Help Predict Cancer Risk
Older biologic age linked to elevated breast cancer risk
New ‘smart drug’ shows promise for metastatic triple-negative breast cancer
T-cell receptor diversity may be key to treatment of follicular lymphoma, study finds